NCT03608020View on ClinicalTrials.gov

A Trial for Treatment of Cancer Patients With Multiple Brain Metastases Undergoing Whole-Brain Radiotherapy

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

October 4, 2018

Primary Completion Date

December 31, 2023

Study Completion Date

April 15, 2024

Conditions
Multiple Brain Metastases
Interventions
DRUG

BMX-001

Manganese butoxyethyl pyridyl porphyrin

RADIATION

Whole Brain Radiation Therapy

Whole Brain Radiation Therapy per standard of care.

Trial Locations (4)

27710

Duke Cancer Institute, Durham

40506

University of Kentucky, Lexington

48202

Henry Ford Hospital, Detroit

98195

University of Washington, Seattle

Sponsors

Lead Sponsor

BioMimetix JV, LLC
All Listed Sponsors
collaborator

Duke Cancer Institute

OTHER

collaborator

National Cancer Institute (NCI)

NIH

lead

BioMimetix JV, LLC

INDUSTRY